Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 1126 AL 1140

Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease

Piper DA, Sastre D, Schüle B.

Front Neurosci. 2018 Apr 9;12:199. doi: 10.3389/fnins.2018.00199. eCollection 2018.

Modeling Parkinson's Disease in Drosophila: What Have We Learned for Dominant Traits?

Xiong Y, Yu J.

Front Neurol. 2018 Apr 9;9:228. doi: 10.3389/fneur.2018.00228. eCollection 2018.

Old wines in new bottles: Repurposing opportunities for Parkinson's disease

Kakkar AK, Singh H, Medhi B.

Eur J Pharmacol. 2018 Jul 5;830:115-127. doi: 10.1016/j.ejphar.2018.04.023. Epub 2018 Apr 22.

Prenatal exposure to oxidative phosphorylation xenobiotics and late-onset Parkinson disease

Iglesias E, Pesini A, Garrido-Pérez N, Meade P, Bayona-Bafaluy MP, Montoya J, Ruiz-Pesini E.

Ageing Res Rev. 2018 Aug;45:24-32. doi: 10.1016/j.arr.2018.04.006. Epub 2018 Apr 22.

Marine-derived protein kinase inhibitors for neuroinflammatory diseases

Ning C, Wang HD, Gao R, Chang YC, Hu F, Meng X, Huang SY.

Biomed Eng Online. 2018 Apr 24;17(1):46. doi: 10.1186/s12938-018-0477-5.

Exosomes and Stem Cells in Degenerative Disease Diagnosis and Therapy

Chang YH, Wu KC, Harn HJ, Lin SZ, Ding DC.

Cell Transplant. 2018 Mar;27(3):349-363. doi: 10.1177/0963689717723636. Epub 2018 Apr 25.

A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?

Cacciari B, Spalluto G, Federico S.

Mini Rev Med Chem. 2018;18(14):1168-1174. doi: 10.2174/1389557518666180423113051.

Toward adaptive deep brain stimulation in Parkinson's disease: a review

Mohammed A, Bayford R, Demosthenous A.

Neurodegener Dis Manag. 2018 Apr;8(2):115-136. doi: 10.2217/nmt-2017-0050. Epub 2018 Apr 25.

Exploiting Botulinum Neurotoxins for the Study of Brain Physiology and Pathology

Caleo M, Restani L.

Toxins (Basel). 2018 Apr 25;10(5):175. doi: 10.3390/toxins10050175.

Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease

Sharma VD, Lyons KE, Pahwa R.

Ther Clin Risk Manag. 2018 Apr 12;14:665-673. doi: 10.2147/TCRM.S144481. eCollection 2018.

Quantifying Motor Impairment in Movement Disorders

FitzGerald JJ, Lu Z, Jareonsettasin P, Antoniades CA.

Front Neurosci. 2018 Apr 11;12:202. doi: 10.3389/fnins.2018.00202. eCollection 2018.

Influence of cognitive impairment on the freezing of gait in non demented people with Parkinson's disease

Cancela JM, Nascimento CM, Varela S, Seijo-Martinez M, Lorenzo-Lopez L, Millan-Calenti JC, Dominguez-Vivero C, Ayan C.

Rev Neurol. 2018 May 1;66(9):289-296.

Subjective and psychological well-being in Parkinson's Disease: A systematic review

Vescovelli F, Sarti D, Ruini C.

Acta Neurol Scand. 2018 Jul;138(1):12-23. doi: 10.1111/ane.12946. Epub 2018 Apr 25.

Cost-Minimization Analysis of Deep-Brain Stimulation Using National Database of Japanese Health Insurance Claims

Akazawa M, Konomura K, Shiroiwa T.

Neuromodulation. 2018 Aug;21(6):548-552. doi: 10.1111/ner.12782. Epub 2018 Apr 26.

New horizons in falls prevention

Lord SR, Close JCT.

Age Ageing. 2018 Jul 1;47(4):492-498. doi: 10.1093/ageing/afy059.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias